Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients.
Vadasz Z, Tal Y, Rotem M, Shichter-Confino V, Mahlab-Guri K, Graif Y, Kessel A, Agmon-Levin N, Maoz-Segal R, Kivity S, Benor S, Lachover-Roth I, Zeldin Y, Stein M, Toker O, Hassoun G, Bezalel-Rosenberg S, Toubi E, Asher I, Sthoeger Z; Israeli Forum for investigating and treating Chronic Spontaneous Urticaria (CSU).
Vadasz Z, et al. Among authors: benor s.
J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1743-1745. doi: 10.1016/j.jaip.2017.08.035. Epub 2017 Oct 4.
J Allergy Clin Immunol Pract. 2017.
PMID: 28988786
No abstract available.